Studying spinal fluid revealed links to MS that blood analysis missed.
Researchers compared proteins in blood and spinal fluid across several conditions involving the brain and nerves. Fewer than 30% of nearly 5,000 genetic links to protein levels appeared in both fluids. They found 427 links between proteins and the risk of 14 conditions. Only 69 of those links appeared in both fluids. Spinal fluid analysis revealed signs of immune activity and cell death related to MS that blood analysis missed.
This study examined blood and spinal fluid data, not a group of people with one form of MS. It included MS among several conditions involving the brain and nerves. The findings matter because blood and spinal fluid did not provide the same information. Spinal fluid revealed MS-related findings that blood missed. The study also found differences between the fluids for other conditions, including Alzheimer's disease.
You cannot use these findings as a new MS test. The abstract does not give the number of people whose samples were studied. It also does not show whether these protein links cause MS or predict what will happen to you.
AI-generated summary — for informational purposes only, not medical advice
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More10/16/2026
Two rare conditions can look like MS. An Italian study links certain treatments to more time without
Read More10/15/2026
Researchers suggest adding a drug after stem cell transplant to help keep MS from returning. Learn h
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Science translational medicine often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.